It cleaves amyloid precursor protein (APP) in vitro, reducing secretion of Aβ peptide, the molecular driver of Alzheimer's disease (AD) (Paschkowsky et al. 2016). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.